関連する実験動画
Updated: May 11, 2026

04:01
Revealing the Ferroptotic Phenotype of Medulloblastoma
Published on: March 15, 2024
テトラヒドロビオプテリンのバイオシンセシスは,硫黄薬のオフターゲットの作用として行われます
Hirohito Haruki1, Miriam Grønlund Pedersen, Katarzyna Irena Gorska
1EPFL, Institute of Chemical Sciences and Engineering, Institute of Bioengineering, National Centre of Competence in Research in Chemical Biology, 1015 Lausanne, Switzerland.
まとめ
スルファメトキサゾールなどの硫黄剤はセピアプテリン還元酵素を阻害し,テトラヒドロビオプテリン (BH4) の合成を阻害する. これは,中枢神経系の副作用のいくつかを説明し,より安全な薬物使用の洞察を提供します.
科学分野:
- バイオケミストリー バイオケミストリー
- 薬理学 薬理学とは
- 分子生物学は分子生物学である.
背景:
- 硫黄薬は細菌感染症治療に革命をもたらしたが,その副作用には明確な分子説明がない.
- 硫黄薬の副作用の分子基盤を理解することは,患者の安全性を改善するために不可欠です.
研究 の 目的:
- 硫黄薬による副作用の背後にある分子メカニズムを解明する.
- 硫黄剤とテトラヒドロビオプテリン (BH4) のバイオシンセシスの相互作用を調査する.
- 硫黄薬に関連する中枢神経系の副作用の論理的根拠を提供するため.
主な方法:
- セピアプテリン還元酵素を用いた酵素抑制アッセイ.
- 硫黄薬に結合するセピアプテリン還元酵素の構造を決定するためのX線結晶学.
- 神経伝達物質のバイオシンセシスを評価するための細胞ベースの測定法.
主要な成果:
- スルファメトキサゾールおよびその他の硫黄剤は,セピアプテリン還元酵素の阻害剤として特定されました.
- 結晶構造は,セピアプテリン還元酵素に対する様々な硫黄薬の特定の結合モードを明らかにした.
- 硫黄薬によるBH4生物合成の抑制は,細胞ベースのアッセイで神経伝達物質合成の減少と関連していました.
結論:
- 硫黄剤はセピアプテリン還元酵素を阻害することによって,テトラヒドロビオプテリン (BH4) のバイオシンセシスに干渉する.
- このメカニズムは,特に高用量療法中に,硫黄薬の中枢神経系副作用に対する分子説明を提供します.
- この発見は,硫黄薬療法を最適化し,副作用を最小限に抑える可能性を秘めている.
関連する概念動画
Sulfur Assimilation
Sulfur is an essential element in biological systems, contributing to synthesizing key biomolecules, including amino acids such as cysteine and methionine, and cofactors such as coenzyme A and biotin. Microorganisms primarily assimilate sulfur as sulfate (SO₄²⁻) from the environment, which must undergo a series of biochemical transformations before it can be incorporated into cellular components. As sulfate is highly oxidized, it must undergo assimilatory sulfate reduction to become...
Phase II Reactions: Sulfation and Conjugation with α-Amino Acids
Sulfation and α-amino acid conjugation are two critical biotransformation reactions in drug metabolism. Sulfation, a phase II biotransformation reaction, involves adding a polar sulfate group to a drug, enhancing its water solubility and promoting excretion. This process can either co-occur with or occur independently of glucuronidation. Nonmicrosomal sulfotransferase enzymes catalyze the process. The reaction involves 3'-phosphoadenosine-5'-phosphosulfate or PAPS coenzyme activation, sulfur...
Drug Metabolism: Phase II Reactions
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Drug Biotransformation: Overview
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
Drug Biotransformation: Overview
Biotransformation, also known as drug metabolism, is a vital physiological process that chemically alters drugs, facilitating their elimination from the body and terminating their action. This process involves two main phases: phase I and phase II reactions. Phase I reactions, including oxidation, reduction, and hydrolysis, introduce or unmask polar functional groups on the drug molecule, thereby increasing its water solubility. By enhancing water solubility, the drug becomes more hydrophilic...
